ARCHIVES

House committee Seeks $239 Million Cut In Clinton’s NIH Budget

This article is from The Cancer Letter archive.

Vol. 20 No. 10 | March 11, 1994

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

January 9, 2004

Two New Modalities Promising For Relapsed/Refractory NHL

January 28, 2005

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

NCI-Approved Clinical Trials

July 30, 2010

DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off

June 1, 2001